Trade PLYX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Polaryx Therapeutics, Inc. (PLYX) is trading at US$2.02, up 1.00% today as of Sep 8, 16:00 EDT. The company has a market capitalisation of US$103.18M. Over the past 52 weeks, PLYX has traded between US$1.85 and US$48.91. On Syfe you can trade PLYX with $0 commission and add it to your watchlist.
| Previous close | US$2.00 |
|---|---|
| Market cap | US$103.18M |
| 52-week range | US$1.85 – US$48.91 |
| Volume | 14.15K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.
Year: 2026
--HC Wainwright Initiates Coverage on Polaryx Therapeutics With Buy Rating, $7 Price Target
Jul 9, 12:33 PM · MT Newswires
Polaryx Says PLX-200 Granted FDA Fast Track Designations for Neurodegenerative Conditions
Apr 21, 2:29 PM · MT Newswires
Polaryx Therapeutics Says FDA Grants Fast Track Status to PLX-200
Mar 17, 1:48 PM · MT Newswires
Polaryx Therapeutics, Inc. (PLYX) stock is trading at US$2.02, +1.00% from the previous close of US$2.00.
The market cap for Polaryx Therapeutics, Inc. (PLYX) stock is approximately US$103.18M.
The 52-week high for Polaryx Therapeutics, Inc. (PLYX) stock is US$48.91.
The 52-week low for Polaryx Therapeutics, Inc. (PLYX) stock is US$1.85.
Polaryx Therapeutics, Inc. (PLYX) does not currently pay a dividend.
Stay on top of PLYX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
